MiR-141 modulates androgen receptor transcriptional activity in human prostate cancer cells through targeting the small heterodimer partner protein

Prostate

Volumn 72, Issue 14, 2012, Pages 1514-1522

  Xiao, Jing ^a,d   Gong, Ai Yu ^a   Eischeid, Alex N ^a   Chen, Dongqing ^a   Deng, Caishu ^b   Young, Charles Y F ^c   Chen, Xian Ming ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

^c Mayo Clinic   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

androgen receptor; microRNAs; miR 141; PEITC; prostate cancer; Shp

Indexed keywords

ANDROGEN RECEPTOR; COREPRESSOR PROTEIN; MICRORNA 141; PHENETHYL ISOTHIOCYANATE; PROTEIN SMALL HETERODIMER PARTNER; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; BRASSICACEAE; CANCER CELL CULTURE; CELL STRAIN LNCAP; CHEMOPROPHYLAXIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; PROTEIN TARGETING; RNA DEGRADATION; RNA TRANSCRIPTION; RNA TRANSLATION; UPREGULATION;

BLOTTING, WESTERN; CELL LINE, TUMOR; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ISOTHIOCYANATES; MALE; MICRORNAS; OLIGONUCLEOTIDES, ANTISENSE; PROSTATIC NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, ANDROGEN; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 84865503446     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22501     Document Type: Article

References (38)

1. Bartel DP,. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004; 116 (2): 281-297.
2. He L, Hannon GJ,. MicroRNAs: Small RNAs with a big role in gene regulation. Nat Rev Genet 2004; 5 (7): 522-531. (Pubitemid 38868508)
3. Anglicheau D, Muthukumar T, Suthanthiran M,. MicroRNAs: Small RNAs with big effects. Transplantation 2010; 90 (2): 105-112.
4. Garzon R, Marcucci G, Croce CM,. Targeting microRNAs in cancer: Rationale, strategies and challenges. Nat Rev Drug Discov 2010; 9 (10): 775-789.
5. Sevli S, Uzumcu A, Solak M, Ittmann M, Ozen M,. The function of microRNAs, small but potent molecules, in human prostate cancer. Prostate Cancer Prostatic Dis 2010; 13 (3): 208-217.
6. Pang Y, Young CYF, Yuan H,. MicroRNAs and prostate cancer. Acta Biochim Biophys Sin 2010; 42 (6): 363-369.
7. Saini S, Majid S, Dahiya R,. Diet, microRNAs and prostate cancer. Pharm Res 2010; 27 (6): 1014-1026.
8. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M,. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008; 105 (30): 10513-10518.
9. Waltering KK, Porkka KP, Jalava SE, Urbanucci A, Kohonen PJ, Latonen LM, Kallioniemi OP, Jenster G, Visakorpi T,. Androgen regulation of micro-RNAs in prostate cancer. Prostate 2011; 71 (6): 604-614.
10. Culig Z, Bartsch G,. Androgen axis in prostate cancer. J Cell Biochem 2006; 99 (2): 373-381. (Pubitemid 44435555)
11. Lamont KR, Tindall DJ,. Androgen regulation of gene expression. Adv Cancer Res 2010; 107: 137-162.
12. Gao L, Alumkal J,. Epigenetic regulation of androgen receptor signaling in prostate cancer. Epigenetics 2010; 5 (2): 100-104.
13. Debes JD, Tindall DJ,. Mechanisms of androgen-refractory prostate cancer. N Engl J Med 2004; 351 (15): 1488-1490. (Pubitemid 39315314)
14. Kahl P, Gullotti L, Heukamp LC, Wolf S, Friedrichs N, Vorreuther R, Solleder G, Bastian PJ, Ellinger J, Metzger E, Schüle R, Buettner R,. Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence. Cancer Res 2006; 66 (23): 11341-11347. (Pubitemid 46009965)
15. Chmelar R, Buchanan G, Need EF, Tilley W, Greenberg NM,. Androgen receptor coregulators and their involvement in the development and progression of prostate cancer. Int J Cancer 2007; 120 (4): 719-733. (Pubitemid 46175390)
16. Seol W, Choi HS, Moore DD,. An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizes with other receptors. Science 1996; 272 (5266): 1336-1339. (Pubitemid 26199974)
17. Lu TT, Makishima M, Repa JJ, Schoonjans K, Kerr TA, Auwerx J, Mangelsdorf DJ,. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol Cell 2000; 6 (3): 507-515.
18. Goodwin B, Jones SA, Price RR, Watson MA, McKee DD, Moore LB, Galardi C, Wilson JG, Lewis MC, Roth ME, Maloney PR, Willson TM, Kliewer SA,. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell 2000; 6 (3): 517-526.
19. Johansson L, Thomsen JS, Damdimopoulos AE, Spyrou G, Gustafsson JÅ, Treuter E,. The orphan nuclear receptor SHP inhibits agonist-dependent transcriptional activity of estrogen receptors ERalpha and ERbeta. J Biol Chem 1999; 274 (1): 345-353. (Pubitemid 29035068)
20. Seol W, Hanstein B, Brown M, Moore DD,. Inhibition of estrogen receptor action by the orphan receptor SHP (short heterodimer partner). Mol Endocrinol 1998; 12 (10): 1551-1557. (Pubitemid 30663437)
21. Nishigori H, Tomura H, Tonooka N, Kanamori M, Yamada S, Sho K, Inoue I, Kikuchi N, Onigata K, Kojima I, Kohama T, Yamagata K, Yang Q, Matsuzawa Y, Miki T, Seino S, Kim MY, Choi HS, Lee YK, Moore DD, Takeda J,. Mutations in the small heterodimer partner gene are associated with mild obesity in Japanese subjects. Proc Natl Acad Sci USA 2001; 98 (2): 575-580. (Pubitemid 32105084)
22. Gobinet J, Auzou G, Nicolas JC, Sultan C, Jalaguier S,. Characterization of the interaction between androgen receptor and a new transcriptional inhibitor, SHP. Biochemistry 2001; 40 (50): 15369-15377. (Pubitemid 33151952)
23. Chiao JW, Wu H, Ramaswamy G, Conaway CC, Chung FL, Wang L, Liu D,. Ingestion of an isothiocyanate metabolite from cruciferous vegetables inhibits growth of human prostate cancer cell xenografts by apoptosis and cell cycle arrest. Carcinogenesis 2004; 25 (8): 1403-1408. (Pubitemid 39172078)
24. Gong AY, He M, Krishna Vanaja D, Yin P, Karnes RJ, Young CY,. Phenethyl isothiocyanate inhibits STAT3 activation in prostate cancer cells. Mol Nutr Food Res 2009; 53 (7): 878-886.
25. Gong AY, Hu G, Zhou R, Liu J, Feng Y, Soukup GA, Chen XM,. MicroRNA-221 controls expression of intercellular adhesion molecule-1 in epithelial cells in response to Cryptosporidium parvum infection. Int J Parasitol 2011; 41 (3-4): 397-403.
26. Gong AY, Zhou R, Hu G, Liu J, Sosnowska D, Drescher KM, Dong H, Chen XM,. Cryptosporidium parvum induces B7-H1 expression in cholangiocytes by downregulating microRNA-513. J Infect Dis 2010; 201 (1): 160-169.
27. Pedersen IM, Cheng G, Wieland S, Volinia S, Croce CM, Chisari FV, David M,. Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 2007; 449 (7164): 919-922. (Pubitemid 47598616)
28. Yuan H, Young CY, Tian Y, Liu Z, Zhang M, Lou H,. Suppression of the androgen receptor function by quercetin through protein-protein interactions of Sp1, c-Jun, and the androgen receptor in human prostate cancer cells. Mol Cell Biochem 2010; 339 (1-2): 253-262.
29. Miyajima N, Maruyama S, Bohgaki M, Kano S, Shigemura M, Shinohara N, Nonomura K, Hatakeyama S,. TRIM68 regulates ligand-dependent transcription of androgen receptor in prostate cancer cells. Cancer Res 2008; 68 (9): 3486-3494.
30. Ding XC, Weiler J, Grosshans H,. Regulating the regulators: Mechanisms controlling the maturation of microRNAs. Trends Biotechnol 2009; 27 (1): 27-36.
31. Zhu R, O'Hara SP, Chen XM,. MicroRNA regulation of innate immune responses in epithelial cells. Cell Mol Immunol 2011; 8 (5): 371-379.
32. Liu J, Valencia-Sanchez MA, Hannon GJ, Parker R,. MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies. Nat Cell Biol 2005; 7 (7): 719-723. (Pubitemid 40975754)
33. Giovannucci E, Rimm EB, Liu Y, Stampfer MJ, Willett WC,. A prospective study of cruciferous vegetables and prostate cancer. Cancer Epidemiol Biomarkers Prev 2003; 12 (12): 1403-1409. (Pubitemid 38031741)
34. Wang LG, Beklemisheva A, Liu XM, Ferrari AC, Feng J, Chial JW,. Dual action on promoter demethylation and chromatin by an isothiocyanate restored GSTP1 silenced in prostate cancer. Mol Carcinog 2007; 46 (1): 24-31. (Pubitemid 46095230)
35. Xiao D, Lew KL, Zeng Y, Xiao H, Marynowski SW, Dhir R, Singh SV,. Phenethyl isothiocyanate-induced apoptosis in PC-3 human prostate cancer cells is mediated by reactive oxygen species-dependent disruption of the mitochondrial membrane potential. Carcinogenesis 2006; 27 (11): 2223-2234. (Pubitemid 44644811)
36. Izzotti A, Larghero P, Cartiglia C, Longobardi M, Pfeffer U, Steele VE, De Flora S,. Modulation of microRNA expression by budesonide, phenethyl isothiocyanate and cigarette smoke in mouse liver and lung. Carcinogenesis 2010; 31 (5): 894-901.
37. Smith TJ, Guo Z, Guengerich FP, Yang CS,. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by human cytochrome P450 1A2 and its inhibition by phenethyl isothiocyanate. Carcinogenesis 1996; 17 (4): 809-813.
38. Xiao D, Singh SV,. Phenethyl isothiocyanate-induced apoptosis in p53-deficient PC-3 human prostate cancer cell line is mediated by extracellular signal-regulated kinases. Cancer Res 2002; 62 (13): 3615-3619. (Pubitemid 34728834)